Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
MKC-1106
/
MannKind
Welcome,
Profile
Billing
Logout
74 Diseases
0 Trials
0 Trials
3 News
|
|||||||||
MKC-1106
/
MannKind
Trial completion, Metastases:
Vaccine Therapy in Treating Patients With Stage IV Melanoma
(clinicaltrials.gov) - Feb 22, 2014
P1/2
, N=19, Completed,
Sponsor: Mannkind Corporation
Active, not recruiting --> Completed
||||||||||
MKC-1106
/
MannKind
Trial termination, IO biomarker, Metastases:
Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma
(clinicaltrials.gov) - Oct 18, 2011
P2
, N=5, Terminated,
Sponsor: Mannkind Corporation
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Financial/Business Reasons
||||||||||
MKC-1106
/
MannKind
Enrollment change, IO biomarker, Metastases:
Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma
(clinicaltrials.gov) - Oct 18, 2011
P2
, N=5, Terminated,
Sponsor: Mannkind Corporation
Active, not recruiting --> Terminated; Financial/Business Reasons N=44 --> 5